IREN
IREN Limited
There isn't enough reported data to score IREN yet.
OPY
Oppenheimer Holdings Inc.
OPY's fundamentals are mixed, but it looks expensive: trading at 12x earnings, above its usual 9.0x.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
OPY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
OPY's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like OPY.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
OPY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.1x | $30.75 | -66% |
| Fair | 9x | $66.53 | -26% |
| Current | 12x | $89.68 | — |
| Expensive | 13x | $93.25 | +4% |
Historical ranges are pointers, not guarantees.
OPY's PE is in its expensive range at 12x.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
OPY Forward outlook
There aren't enough analyst estimates for OPY to show an outlook.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
OPY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $7.43 | -0.3% |
| Q2 2026 | $8.86 | +15% |
| Q1 2026 | $8.39 | +25% |
| Q4 2025 | $13.04 | +105% |
| Q3 2025 | $7.45 | +15% |
| Q2 2025 | $7.71 | +40% |
| Q1 2025 | $6.72 | +80% |
| Q4 2024 | $6.37 | +146% |
OPY has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
OPY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $382M | -10% |
| Q2 2026 | $454.9M | +22% |
| Q1 2026 | $445.1M | +21% |
| Q4 2025 | $472.6M | +26% |
| Q3 2025 | $424.4M | +14% |
| Q2 2025 | $373.2M | +13% |
| Q1 2025 | $367.8M | +4.2% |
| Q4 2024 | $375.4M | +22% |
OPY's revenue is growing: $382M last quarter, down 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.3% | -5.2 points |
| Q2 2026 | 8.7% | 0 points |
| Q1 2026 | -6.1% | -17 points |
| Q4 2025 | 22% | +18 points |
| Q3 2025 | 7.5% | -2 points |
| Q2 2025 | 8.6% | +3.8 points |
| Q1 2025 | 11% | +0.6 points |
| Q4 2024 | 4.5% | -1.2 points |
OPY has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
OPY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $128.6M | +107% |
| Q2 2026 | -$57.1M | -247% |
| Q1 2026 | -$190M | -$96.6M |
| Q4 2025 | $175.8M | +146% |
| Q3 2025 | $62.2M | +455% |
| Q2 2025 | $38.9M | +$155.6M |
| Q1 2025 | -$93.4M | -$14.1M |
| Q4 2024 | $71.5M | +17% |
OPY has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
OPY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +103K shares |
| 1 year | +1.2% | +136K shares |
| 3 years | +1.3% | +146K shares |
| 5 years | -15% | -2.1M shares |
| Available history | -16% | -2.3M shares |
OPY has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $2.3M |
| Q3 2025 | — |
| Q2 2025 | $581,000 |
| Q1 2025 | $90,000 |
| Q4 2024 | — |
OPY spent $2M buying back its own shares over the past year, about three times what it spent the year before.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
OPY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 1.5x | Healthy |
| Q3 2023 | 1.2x | Healthy |
| Q2 2023 | 1.6x | Healthy |
| Q1 2023 | 1.4x | Healthy |
| Q4 2022 | 0.0x | Very low |
| Q3 2022 | 0.8x | Very low |
| Q2 2022 | 0.6x | Very low |
| Q1 2022 | 0.4x | Very low |
OPY's net debt is about 1.5 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like OPY.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
OPY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 14.4 | Oversold |
OPY's weekly RSI is 39 (neutral) and its Stochastic is 14 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
OPY PE vs Financial Services Sector
| Metric | OPY | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.3% below |
| PE % | 80 | 63 | 17 pts above |
OPY is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
OPY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $102.8 | 13% below |
| 20 week MA | $109.8 | 18% below |
| 50 week MA | $97.5 | 8.1% below |
| 100 week MA | $82.0 | 9.4% above |
| 200 week MA | $62.7 | 43% above |
OPY has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
OPY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.8 | $31.7 | +14% |
| 2021 | $31.7 | $44.2 | +39% |
| 2022 | $44.2 | $42.8 | -3.2% |
| 2023 | $42.8 | $41.3 | -3.4% |
| 2024 | $41.3 | $64.5 | +56% |
| 2025 | $64.5 | $74.2 | +15% |
| 2026 YTD | $74.2 | $89.7 | +21% |
OPY has the edge over IREN on returns for 2026, with the stronger performance.